Review
Accepted on 17 Jul 2026
Progression-related outcomes of Teriflunomide in Multiple Sclerosis Clinical Trials
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Type at least 3 characters
1,237 articles
articles
Original Research
Published on 16 Jul 2026
Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1840196
- 664 views
Original Research
Published on 14 Jul 2026
Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing–remitting multiple sclerosis: a case–control study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1851383
- 485 views
Original Research
Published on 14 Jul 2026
Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1822692
- 300 views
Brief Research Report
Accepted on 13 Jul 2026
The Treatment With or Without Prednisolone in Adults Aged ≥ 70 Years With Myasthenia Gravis: A Retrospective Cohort Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 115 views
Editorial
Accepted on 13 Jul 2026
Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
Review
Published on 13 Jul 2026
Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1853951
- 2,183 views
Original Research
Published on 09 Jul 2026
Circular RNA circNUP214 serves as a microRNA-31 sponge to promote the progression of myasthenia gravis through NFAT5
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1807844
- 408 views
Review
Accepted on 06 Jul 2026
Neuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 271 views
Original Research
Published on 01 Jul 2026
Risk of macrovascular events among patients with ICD-defined neuromyelitis optica in Taiwan
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1799026
- 1,025 views
Original Research
Published on 01 Jul 2026
Burden level and influencing factors of caregivers for patients with autoimmune encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1763795
- 601 views
Brief Research Report
Published on 24 Jun 2026
Neuronal expression of β2M and MHC I are essential for peripheral surveillance and targeting of neuron-restricted antigens
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1813496
- 873 views
Review
Published on 24 Jun 2026
Serum neurofilament light chain in multiple sclerosis: from biological signal to clinically informed decision-making
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1815022
- 1,132 views
Original Research
Accepted on 22 Jun 2026
Association of Therapeutic Plasma Exchange with Functional Outcomes in Selected Neurological Disorders: A Retrospective Cohort Study from a Single Tertiary Center in Saudi Arabia
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 529 views
Original Research
Accepted on 22 Jun 2026
Association Between Peripheral Blood T Cell Subsets and Clinical Disability in Multiple Sclerosis Patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
- 349 views
Correction
Published on 22 Jun 2026
Correction: Novel surrogate markers of CNS inflammation in CSF in the diagnosis of autoimmune encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1842731
- 649 views
Original Research
Published on 19 Jun 2026
Quality of life and its influencing factors in patients with neuromyelitis optica spectrum disorder
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1797747
- 1,240 views
Original Research
Published on 18 Jun 2026
Symptom clusters mediate anxiety/depression effects on quality of life in neuromyelitis optica spectrum disorders: a cross-sectional mediation analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1753642
- 1,084 views
Original Research
Published on 16 Jun 2026
A combined therapeutic approach: extracorporeal shock wave therapy and botulinum toxin in multiple sclerosis-related spasticity
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1851860
- 1,071 views
Review
Published on 09 Jun 2026
Menopause and ageing in women with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1838550
- 1,489 views
Original Research
Published on 03 Jun 2026
Global overview of multiple sclerosis care units: an international cross-sectional survey
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1812690
- 1,565 views
Study Protocol
Published on 29 May 2026
Safety and efficacy of combined B-cell depleting therapy and daratumumab in patients with autoimmune encephalitis (RADIA): study protocol for a multicenter, randomized trial
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1783651
- 1,523 views
Review
Published on 28 May 2026
Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1812340
- 1,994 views
Systematic Review
Published on 26 May 2026
A network meta-analysis of the performance of acupoint stimulation therapy in improving fatigue, neurological function, and activities of daily living in patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2026.1796876
- 1,725 views